Company Description
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.
It operates through The Dental Segment. The company offers dental implant systems; biomaterials; prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name.
It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service.
The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors.
ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida with additional facilities around the globe.
Country | United States |
Founded | 2021 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 2,600 |
CEO | Vafa Jamali |
Contact Details
Address: 4555 Riverside Drive Palm Beach Gardens, Florida 33410 United States | |
Phone | 303 443 7500 |
Website | zimvie.com |
Stock Details
Ticker Symbol | ZIMV |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001876588 |
CUSIP Number | 98888T107 |
ISIN Number | US98888T1079 |
SIC Code | 3843 |
Key Executives
Name | Position |
---|---|
Vafa Jamali | President, Chief Executive Officer and Director |
Richard J. Heppenstall | Executive Vice President, Chief Financial Officer and Treasurer |
Heather Kidwell | Senior Vice President, Chief Legal, Human Resources and Compliance Officer and Corporate Secretary |
Indraneel Kanaglekar | Senior Vice President and Chief Commercial Officer |
Sandra Schneider | Chief Accounting Officer |
Steve Rondeau | Senior Vice President and Chief Information Officer |
Ann Vu | SVice President and Chief Quality and Regulatory Affairs Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Oct 30, 2024 | 10-Q | Quarterly Report |
Oct 30, 2024 | 8-K | Current Report |
Oct 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Aug 1, 2024 | 10-Q | Quarterly Report |
Aug 1, 2024 | 8-K | Current Report |
Jul 2, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
May 24, 2024 | SD | Form - SD |
May 17, 2024 | 8-K | Current Report |